The value of positron emission tomography scan in predicting pathologic response of non-small cell lung cancer managed by neoadjuvant chemo-immunotherapy

作者
Louis-Emmanuel Chriqui,Maged Zaher,Etienne Abdelnour‐Berchtold,Hasna Bouchaab,Nuria Mederos,Sabina Berezowska,Michel Gonzalez,Matthieu Zellweger,Solange Peters,Thorsten Krueger,Niklaus G. Schaefer,Jean Yannis Perentes
出处
期刊:Journal of Thoracic Disease [AME Publishing Company]
卷期号:18 (2): 115-115 被引量:1
标识
DOI:10.21037/jtd-2025-1686
摘要

Background: Neoadjuvant chemo-immunotherapy improves overall survival in resectable stage II–III non-small cell lung cancer (NSCLC). Post-induction re-staging remains challenging and typically relies on contrast-enhanced computed tomography (CT). We assessed the predictive value of 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography/computed tomography (PET/CT) for tumor pathologic response and patient survival after induction therapy. Methods: We analyzed all stage II–III, node-positive NSCLC patients from a collected database [2017–2023] who received neoadjuvant chemo-immunotherapy followed by surgery, with pre- and post-induction cancer assessment by 18F-FDG PET/CT. We identified 37 patients and determined their demographic characteristics, initial tumor burden, surgical outcomes, pathologic response and overall survival. We then correlated cancer pathologic response and patient overall survival with the mean and max standard uptake value change (ΔSUV) of the primary tumor and lymph nodes between the pre- and post-induction 18F-FDG PET/CTs using receiver operating characteristic (ROC) and Kaplan-Meier analyses, respectively. Results: Seventeen women and 20 men (mean age 64±7 years) had mostly stage III adenocarcinomas. Open lobectomies (59%) were the most common procedures. Ninety-two percent of resections were R0. Major pathologic response (MPR) and pathologic complete response (pCR) occurred in 51% and 30% of patients, respectively. Mean/max tumor ΔSUV predicted pCR [area under the curve (AUC) =0.8135, P=0.004/AUC =0.8086, P=0.0045] but mean/max lymph node ΔSUV predicted pCR better (AUC =0.9044, P<0.001/AUC =0.8990, P<0.001). A 70% decrease in lymph node ΔSUVmax between pre- and post-induction PET/CT predicted pCR with a sensitivity of 88% and a specificity of 78% and correlated with patient overall survival. Conclusions: Significant decrease in lymph node ΔSUVmax on PET/CT after neoadjuvant chemo-immunotherapy strongly predict pCR and overall survival. Further prospective validation is required.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
现代的雁凡完成签到,获得积分10
刚刚
刚刚
刚刚
zqy发布了新的文献求助10
刚刚
给里奥完成签到,获得积分10
刚刚
eryaclover完成签到,获得积分10
刚刚
老乔发布了新的文献求助30
1秒前
1秒前
王某某发布了新的文献求助10
1秒前
万荼巳蕊完成签到,获得积分10
1秒前
西大喜完成签到,获得积分10
1秒前
冰_完成签到 ,获得积分10
1秒前
晴日海风吹完成签到,获得积分10
1秒前
2秒前
Lucas的应助被1101592875采纳,获得10
2秒前
迅速冬瓜完成签到,获得积分10
2秒前
2秒前
吹球球8发布了新的文献求助10
2秒前
李淼完成签到 ,获得积分10
3秒前
3秒前
3秒前
聚乙二醇发布了新的文献求助10
5秒前
chris完成签到,获得积分10
5秒前
zzZ5发布了新的文献求助30
5秒前
5秒前
传奇3的应助被超级曼安采纳,获得10
5秒前
无限灵松完成签到 ,获得积分10
5秒前
落木完成签到,获得积分10
5秒前
5秒前
沫沫完成签到 ,获得积分0
5秒前
6秒前
6秒前
白马完成签到,获得积分10
6秒前
6秒前
6秒前
6秒前
jasmine970000发布了新的文献求助10
6秒前
Echo完成签到,获得积分10
7秒前
谁有文献请救救我完成签到,获得积分10
7秒前
yaosan完成签到,获得积分10
7秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8180713
求助须知:如何正确求助?哪些是违规求助? 9570752
关于积分的说明 21814119
捐赠科研通 7776960
什么是DOI,文献DOI怎么找? 3433298
关于科研通互助平台的介绍 2557579
邀请新用户注册赠送积分活动 2479287